Johnson & Johnson (NYSE:JNJ)

Achillion Pharmaceuticals Gears Up for Secondary Offering

Shares of Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) saw a handy gain on Thursday after the company announced a secondary offering. While the offering is set to close on November 20, ...
Read Full Story »

UBS Dividend Ruler Stocks Stay Hot: 4 to Buy for 2018

One of the best way for investors to have consistent gains in the stock market is to stay invested. Jumping in and out and trying to time the market is ...
Read Full Story »

Analysts Piling On to Raise Johnson & Johnson Price Targets Higher and Higher

Johnson & Johnson (NYSE: JNJ) is one of those Dow Jones Industrial Average companies that seems to just keep chugging ever higher over time. The company has greatly exceeded its ...
Read Full Story »

UnitedHealth, Johnson & Johnson Lead Dow Higher Tuesday

October 17, 2017: Markets opened mixed Tuesday after a day of record highs (again) on Monday. The DJIA topped 23,000 for the first time ever as the nation's homebuilder posted ...
Read Full Story »

Johnson & Johnson Pharmaceutical, Domestic Sales Fuel Growth

Johnson & Johnson (NYSE: JNJ) reported its fiscal third-quarter financial results before the markets opened on Tuesday. The company said that it had $1.90 in earnings per share (EPS) and ...
Read Full Story »

Goldman Sachs and More Dow Earnings Kicking Off Tuesday

When 2016 came to a close, analysts were predicting that the Dow Jones Industrial Average would end 2017 at 22,000. At least this is what the more bullish analysts were ...
Read Full Story »

Goldman Sachs, GE, Verizon and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week. Overall, seven companies in the Dow are ...
Read Full Story »

Walmart, Johnson & Johnson Lift DJIA Wednesday

October 11, 2017: Markets opened mixed Wednesday and trading was choppy during the first couple of hours before settling on an up-and-to-the-right trend. The leading sectors were real estate and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

Stocks were indicated to open marginally lower on Wednesday morning, but that is after the Dow hit new all-time highs on Tuesday and has come within 170 points of hitting ...
Read Full Story »

Deutsche Bank Adds 5 Large Cap Leaders to Conviction List

With the last quarter of 2017 underway, and a rash of third-quarter earnings ready to hit the tape, many of the top firms we cover here at 24/7 Wall St. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Ctrip, Goldman Sachs, Johnson & Johnson, Medtronic, Morgan Stanley, Yelp, Yum China and More

Stocks were indicated to open higher on Monday morning, partly led by overseas markets and a gain in China. The S&P 500 and Dow Jones Industrial Average hit all-time highs ...
Read Full Story »

Credit Suisse Identifies Top Mid-Large Cap Biotech and Pharma Stocks for Big Upside

U.S. pharmaceutical and biotech stocks may have considerable upside if Credit Suisse's views come to pass. The firm is looking at pharma and biotech opportunities around politics, drug pipelines and ...
Read Full Story »

Major Biotech, Pharma and FDA Catalysts Coming in October

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Stocks were looking for direction on Monday morning after hitting all-time highs last week. The primary trend that has dominated this eight-year bull market is that investors keep finding new ...
Read Full Story »

Apple, Procter & Gamble Sink the DJIA Thursday

September 21, 2017: Markets opened lower Thursday while equities traders try to read the FOMC tea leaves for a rate hike by the end of this year. The Fed will ...
Read Full Story »